Healthcare providers can perform targeted assessment including thyroid function tests, cardiovascular evaluation, and review of concurrent medications that might contribute to vasomotor symptoms
Small studies in humans have not shown that GLP-1 agonists and other medications for diabetes increase the risk of major birth defects
Beyond Novo and Eli Lilly, companies such as Boehringer Ingelhium, Pfizer, Roche, AstraZeneca, Regor therapeutics, Viking Therapeutics, Amgen, BioAge Labs, Gan & Lee Pharmaceuticals, Sun Pharma, Innovent Biologics, Aphaia Pharma, Vertex Pharmaceuticals , and others are entering the space, fueling new innovations in GLP-1 therapies, combination therapies, and next-gen metabolic treatments
You can pinch it
P = .35), and triple-negative breast cancer (RR, 0.68
Contraindications Pregnancy and breastfeeding represent absolute contraindications due to BPC-157s cell proliferative effects and lack of safety data in these populations